RMTG — Regenerative Medical Technology Group Inc.
—
OTC ·
Consumer Discretionary ·
Specialty Retail ·
CIK 1760026 ·
Last close
$0.12
Market Cap
$1.58M
52W High
$0.12
52W Low
$0.02
ADV30
137,374
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 2,639,353 | 1,766,491 | 229,783 | -876,274 | 5,009,582 | 1,061,448 | 40,630,891 |
| Dec 2025 | 1,571,922 | 779,495 | -306,274 | -1,392,843 | 4,488,694 | 956,718 | 39,233,729 |
| Sep 2025 | 1,180,534 | 501,557 | -445,761 | -4,353,741 | 4,519,827 | 1,185,695 | 34,574,268 |
| Jun 2025 | 983,518 | 585,832 | -250,086 | -1,305,785 | 4,486,828 | 1,614,254 | 33,508,078 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-661,504
Investing CF
$-917,977
Financing CF
$1,418,000
CapEx
$-857,395
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.58
As of
2026-08-23
Balance + Analyst (yfinance extras)
Retained Earnings
$-76,241,785
Inventory
$298,201
Receivables
$34,821
ST Investments
—
EBIT TTM
$815,834
Pretax Income TTM
$-7,928,645
Interest Exp TTM
$8,744,479
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$9,414,572
EBITDA
$493,149
Free Cash Flow
$5,950,848
Enterprise Value
$21,654,642
Total Cash
$1,323,304
Total Debt
$21,740,378
Shares Out
13,738,968
Trailing EPS
$-0.87
Book Value
$-2.65
ROE
—
ROA
1.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 5,100,315 | -867,162 | -7,812,409 | 4,488,694 | 39,233,729 | — | -706,519 |
| Dec 2024 | 4,107,494 | 81,181 | -5,562,971 | 3,821,429 | 31,178,102 | — | 850,699 |
| Dec 2023 | 2,409,953 | -715,227 | -9,813,666 | 2,879,103 | 24,674,606 | — | -419,199 |
| Dec 2022 | 1,530,223 | -1,184,859 | -5,506,822 | 8,080,273 | 20,062,565 | — | -1,114,136 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| JZXN | Jiuzi Holdings, Inc. | $1.74M | $1.31 | — |
| SNBH | SENTIENT BRANDS HOLDINGS INC. | $1.35M | $0.35 | — |
| IZM | ICZOOM Group Inc. | $1.93M | $0.24 | — |
| FBCD | FBC Holding, Inc. | $2.03M | $0.00 | — |
| JEM | 707 Cayman Holdings Ltd. | $2.44M | $3.82 | — |
News headlines (Yahoo Finance, 1h cache)
Global Stem Cells Group (OTC:RMTG) Launches ISSCA Mobile App, Advancing Its Buildout of a Global Digital Ecosystem for Regenerative Medicine
2026-06-17 11:01 · Yahoo
RMTG More Than Quadruples Revenue and Gross Profit in Q2 2026 Versus Q2 2025, With Operating Income Surpassing $560,000
2026-08-20 11:01 · Yahoo
RMTG Provides Details for First-Ever Investor Call to Answer Shareholder Questions
2026-08-19 23:25 · Yahoo
RMTG's Cellgenic Division Launches Natural Killer (NK) Cell Product Line for International Markets
2026-08-24 11:01 · Yahoo
RMTG Expands Cellgenic's Cancún Laboratory Infrastructure with Two Additional ISO 7 Clean Rooms
2026-08-18 11:00 · Yahoo
RMTG Expands Cellgenic Operations Into Argentina, Establishing a Strategic Commercial Hub for Regenerative Medicine in Latin America
2026-07-23 11:02 · Yahoo
RMTG Launches ISSCA AI(TM) Clinical Intelligence Platform, Extending Its Global Regenerative Medicine Network Into AI-Driven Clinical Infrastructure
2026-06-23 11:01 · Yahoo
RMTG Surges 93% in Revenue, 87% in Gross Profit and 70% in Operating Income for Q1 2026 vs Q1 2025
2026-06-10 11:01 · Yahoo
RMTG to Hold First-Ever Investor Call to Discuss Second Quarter 2026 Results
2026-08-05 11:01 · Yahoo
RMTG Subsidiary Cellgenic Commences Full-Scale Manufacturing at First-of-Its-Kind
2026-03-26 11:55 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.